Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OliveXtract is an Australian biotechnology company specializing in the extraction and purification of bioactive compounds from olive leaves. The company utilizes a proprietary, solvent-free, low-temperature extraction process to produce high-potency ingredients, specifically focusing on standardized levels of oleuropein and hydroxytyrosol. These extracts are supplied to the global nutraceutical, functional food, and beverage industries for use in health-promoting products. OliveXtract emphasizes sustainable sourcing and scientific validation to support cardiovascular, metabolic, and immune health. The company's technology ensures the preservation of heat-sensitive polyphenols by processing fresh leaves shortly after harvest.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OliveXtract.